NervGen Pharma Corp. Common stock (NGEN)
Stock · NASDAQ · Health Care
$2.27as of 8/28/2026
Price chart
Open in TradingViewAbout NGEN
NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company's lead product candidate is NVG-291 that is in Phase 1b/2a clinical trial for the treatment of spinal cord injuries (SCI), stroke, multiple sclerosis, and Alzheimer's disease; and NVG-300…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 9
- Website
- www.nervgen.com/
Fundamentals
- 1-day range
- $2.25$2.4
- Market cap
- $141.37M
- P/E (trailing)
- —
- P/E (forward)
- -6.68
- EPS (trailing)
- $-0.36
- Dividend yield
- —
- Beta
- 1.45
- Avg. volume
- 712.3K
52-week range
$3.2$8.49
Next earnings: November 23, 2026 · EPS estimate $-0.11
Forecasts
1 analyst ratings
Buy 88%
Hold 13%
Sell 0%
1-year price forecast
High
$10
+340.5%
Median
$10
+340.5%
Low
$10
+340.5%
NervGen Pharma Corp. Common stock Competitors
Chosen by industry and closest market cap.
- NGENNervGen Pharma Corp. Common stock$2.27▼ 2.78%Market cap $141.37MP/E —$3.2$8.49
- KZIAKazia Therapeutics Limited American Depositary Shares$13.59▼ 19.59%Market cap $140.89MP/E —$4.86$17.4
- OGIOrganigram Global Inc. Common Shares$1.22▼ 0.81%Market cap $139.37MP/E —
- CNTNCanton Strategic Holdings Inc. Common Stock$2.23▼ 5.32%Market cap $143.45MP/E —$1.75$7.25
- ADCTADC Therapeutics SA Common Shares$1.15▲ 2.68%Market cap $143.73MP/E —$0.7796$4.98
- CNTBConnect Biopharma Holdings Limited Ordinary Shares$2.22▼ 2.63%Market cap $137.89MP/E —$1.23$3.82
- VTVTvTv Therapeutics Inc. Class A Common Stock$32.17▼ 1.92%Market cap $136.33MP/E 55.59$15.79$44
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| NGEN NervGen Pharma Corp. Common stock | $141.37M | — | $2.27 | ▼ 2.78% | $3.2$8.49 |
| KZIA Kazia Therapeutics Limited American Depositary Shares | $140.89M | — | $13.59 | ▼ 19.59% | $4.86$17.4 |
| OGI Organigram Global Inc. Common Shares | $139.37M | — | $1.22 | ▼ 0.81% | |
| CNTN Canton Strategic Holdings Inc. Common Stock | $143.45M | — | $2.23 | ▼ 5.32% | $1.75$7.25 |
| ADCT ADC Therapeutics SA Common Shares | $143.73M | — | $1.15 | ▲ 2.68% | $0.7796$4.98 |
| CNTB Connect Biopharma Holdings Limited Ordinary Shares | $137.89M | — | $2.22 | ▼ 2.63% | $1.23$3.82 |
| VTVT vTv Therapeutics Inc. Class A Common Stock | $136.33M | 55.59 | $32.17 | ▼ 1.92% | $15.79$44 |
P/E shows — for peers not currently carrying a live signal of their own.
Institutional Ownership
March 31, 2026
- Total shares held
- 1.67M
- Total value held
- $6.17M
- Institutional holders
- 43
Top holders this quarter
- Unknown201.0K
- Unknown200.7K
- Unknown200.4K
- Unknown172.0K
- Unknown86.8K
- Unknown77.7K
- Unknown62.9K
- Unknown62.4K
- Unknown61.5K
- Unknown40.0K
See the full, filterable feed with live charts on the MarketWall dashboard.